These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7138580)

  • 1. On the mechanism of presynaptic autoreceptor-mediated inhibition of transmitter synthesis in dopaminergic nerve terminals.
    Bitran M; Bustos G
    Biochem Pharmacol; 1982 Sep; 31(18):2851-60. PubMed ID: 7138580
    [No Abstract]   [Full Text] [Related]  

  • 2. Presynaptic dopamine receptors in striatal nerve endings: absence of haloperidol-induced supersensitivity.
    Raiteri M; Cerrito F; Casazza G; Levi G
    Adv Biochem Psychopharmacol; 1980; 24():37-43. PubMed ID: 7405669
    [No Abstract]   [Full Text] [Related]  

  • 3. Receptor reserve at striatal dopamine receptors modulating the release of [3H]dopamine.
    Yokoo H; Goldstein M; Meller E
    Eur J Pharmacol; 1988 Oct; 155(3):323-7. PubMed ID: 3234490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional damage of dopamine nerve terminals following intrastriatal kainic acid injection.
    Bonanno G; Fedele E; Versace P; Raiteri M
    Brain Res; 1989 Feb; 480(1-2):242-8. PubMed ID: 2713653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine biosynthesis is regulated by the amine newly recaptured by dopaminergic nerve endings.
    Cerrito F; Raiteri M
    Eur J Pharmacol; 1980 Dec; 68(4):465-70. PubMed ID: 7202503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of potassium channel blockers.
    Tepper JM; Sawyer SF; Young SJ; Groves PM
    Brain Res; 1986 Mar; 367(1-2):230-7. PubMed ID: 2421831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do presynaptic autoreceptors control dopamine release?
    Raiteri M; Cervoni AM; del Carmine R; Levi G
    Nature; 1978 Aug; 274(5672):706-8. PubMed ID: 209343
    [No Abstract]   [Full Text] [Related]  

  • 8. Is the release of dopamine from medial prefrontal cortex modulated by presynaptic receptors? Comparison with nigrostriatal and mesolimbic terminals.
    Cubeddu LX; Hoffmann IS; Talmaciu RK
    Ann N Y Acad Sci; 1990; 604():452-61. PubMed ID: 2171402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonstriatal dopaminergic neurons: role of presynaptic receptors in the modulation of transmitter synthesis.
    Roth RH; Nowycky MC
    Adv Biochem Psychopharmacol; 1977; 16():465-70. PubMed ID: 18895
    [No Abstract]   [Full Text] [Related]  

  • 10. Presynaptic regulation of dopamine release in corpus striatum monitored in vitro in real time by fast cyclic voltammetry.
    Palij P; Bull DR; Sheehan MJ; Millar J; Stamford J; Kruk ZL; Humphrey PP
    Brain Res; 1990 Feb; 509(1):172-4. PubMed ID: 2137719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW; Slimovitch C; Toffano G
    Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The autoreceptor control of dopamine synthesis. An in vitro and in vivo comparison of dopamine agonists.
    Haubrich DR; Pflueger AB
    Mol Pharmacol; 1982 Jan; 21(1):114-20. PubMed ID: 6127616
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of dopamine synthesis in rat striatal minces: evidence of dopamine autoreceptor supersensitivity to S(+)- but not R(-)-N-n-propylnorapomorphine after pretreatment with fluphenazine.
    Booth RG; Baldessarini RJ; Campbell A
    Biochem Pharmacol; 1991 Jun; 41(12):2040-3. PubMed ID: 1674873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of apomorphine in vitro on the uptake and release of catecholamines in crude synaptosomal preparations of rat striatum and hypothalamus.
    Ferris RM; Tang FL; Russell AV
    Biochem Pharmacol; 1975 Aug; 24(16):1523-7. PubMed ID: 1191310
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of haloperidol and apomorphine on the K+-depolarized overflow of [3H] dopamine from rat striatal slices.
    Miller JC; Friedhoff AJ
    Biochem Pharmacol; 1979 Mar; 28(5):688-90. PubMed ID: 444255
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals.
    Quirion R; Chiueh CC; Everist HD; Pert A
    Brain Res; 1985 Feb; 327(1-2):385-9. PubMed ID: 2985182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
    Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
    [No Abstract]   [Full Text] [Related]  

  • 18. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
    Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (+)-6,7-benzomorphan sigma ligands stimulate dopamine synthesis in rat corpus striatum tissue.
    Booth RG; Baldessarini RJ
    Brain Res; 1991 Aug; 557(1-2):349-52. PubMed ID: 1684130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of pertussis toxin on autoreceptor-mediated inhibition of dopamine synthesis in the rat striatum.
    Bean AJ; Shepard PD; Bunney BS; Nestler EJ; Roth RH
    Mol Pharmacol; 1988 Dec; 34(6):715-8. PubMed ID: 2974120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.